Environmental impact of colorectal cancer screening with colonoscopy and multi-target stool DNA (mt-sDNA) testing

被引:0
|
作者
Alcock, Rebecca [1 ,2 ]
Shaukat, Aasma [3 ]
Kisiel, John B. [4 ]
Hernandez, Lyndon, V [5 ,6 ]
Delarmente, Benjo A. [7 ]
Estes, Chris [1 ]
Bartels, Jeff [1 ]
Lester, Jason [1 ]
Vahdat, Vahab [1 ]
Limburg, Paul J. [1 ]
Fendrick, A. Mark [8 ,9 ]
机构
[1] Exact Sci Corp, Madison, WI 53719 USA
[2] Univ Wisconsin Madison, Dept Ind & Syst Engn, Madison, WI 53706 USA
[3] NYU Grossman Sch Med, Dept Med, Div Gastroenterol, New York, NY 10016 USA
[4] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
[5] Med Coll Wisconsin, Div Gastroenterol, Milwaukee, WI 53226 USA
[6] GI Associates, Milwaukee, WI 53215 USA
[7] Univ Calif Los Angeles, Div Gen Internal Med & Hlth Serv Res, David Geffen Sch Med, UCLA Value Based Care Res Consortium, Los Angeles, CA 90024 USA
[8] Univ Michigan, Div Gen Med, Dept Internal Med, Ann Arbor, MI 48109 USA
[9] Univ Michigan, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA
来源
HEALTH AFFAIRS SCHOLAR | 2025年 / 3卷 / 03期
关键词
colorectal cancer screening; sustainability; colonoscopy; mt-sDNA; multi-target stool-DNA; environmental impact;
D O I
10.1093/haschl/qxaf041
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The substantial carbon footprint imparted by medical services warrants increased attention to their environmental impact. National guideline organizations such as the US Preventive Services Task Force (USPSTF) recommend multiple modalities for average-risk colorectal cancer (CRC) screening with varying resource intensity. The aim of this study was to quantify the environmental burden for 2 of the most used CRC screening modalities, colonoscopy and the multi-target stool DNA (mt-sDNA) test. A validated CRC microsimulation model was used to estimate the number of screening and follow-up tests for a cohort of 1 million average-risk individuals who underwent screening between ages 45 and 75. Component resources used for mt-sDNA, including waste products, energy, and transportation for colonoscopy and mt-sDNA, were collected from January 1, 2023, to January 1, 2024, and converted to carbon-equivalent emissions. Resources used for colonoscopy were captured from the literature. Resources devoted to screening colonoscopy were substantially (59%) higher than those to mt-sDNA, even when including follow-up colonoscopy. Of note, follow-up colonoscopy accounted for the majority (64%) of total emissions for the mt-sDNA screening strategy. Compared with colonoscopy screening, mt-sDNA substantially reduces the carbon emissions attributable to population-level CRC screening. Environmental impact should be included as a factor when choosing among guideline-recommended CRC screening strategies. The health care sector is responsible for over 4% of the global carbon footprint. The environmental impact can be reduced by prioritizing lower-carbon options when there are multiple choices available, as with average-risk colorectal cancer (CRC) screening. We used modeling to compare the impact of 2 commonly used CRC screening methods: colonoscopy and the multi-target stool DNA (mt-sDNA) test. Resource use was calculated, including waste and energy consumption from screening, patient travel, and test kit shipping. The estimated carbon-equivalent emissions for screening colonoscopy were 59% higher than for mt-sDNA, and most emissions from mt-sDNA were from follow-up colonoscopy after a positive test result. The reduced environmental impact of mt-sDNA screening as compared with colonoscopy is 1 factor that can be considered when choosing among guideline-recommended CRC screening options. The environmental impact of colorectal cancer screening with noninvasive multi-target stool DNA (mt-sDNA) was compared with colonoscopy. There were 59% more carbon-equivalent emissions with a colonoscopy screening strategy as compared with mt-sDNA. Most emissions incurred by the mt-sDNA strategy were attributable to follow-up colonoscopy after a positive mt-sDNA result. The results demonstrate that the environmental impact of colorectal cancer screening varies significantly across guideline-endorsed options. Environmental considerations could serve as an additional criterion for patients choosing a screening modality.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Colorectal cancer screening: The role of MT-sDNA testing
    Mollman, Burton James
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2023, 36 (08): : 15 - 20
  • [2] Analysis of mt-sDNA for Colorectal Cancer Screening
    Kopera, Ann
    Woo, Stephanie M.
    Kanth, Priyanka
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S270 - S271
  • [3] MULTI-TARGET STOOL DNA TESTING FOR COLORECTAL CANCER SCREENING IN CLINICAL PRACTICE
    Jiang, Linda
    Vajravelu, Ravy K.
    Byerly, Amy R.
    Schoen, Robert E.
    GASTROENTEROLOGY, 2023, 164 (06) : S267 - S268
  • [4] Performance Evaluation of a Next-Generation Multitarget Stool DNA (mt-sDNA) Screening Test for Colorectal Cancer (CRC)
    Imperiale, Thomas F.
    Gagrat, Zubin D.
    Krockenberger, Martin
    Olson, Marilyn C.
    Porter, Kyle
    Limburg, Paul J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S256 - S257
  • [5] Adherence to multi-target stool DNA testing for colorectal cancer screening in the United States
    Le, Quang A.
    Greene, Mallik
    Gohil, Shrey
    Ozbay, A. Burak
    Dore, Michael
    Fendrick, A. Mark
    Limburg, Paul
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2025, 40 (01)
  • [6] Impact of mt-sDNA in a Colorectal Cancer Screening Clinical Practice: A Real-World Survey
    Miller-Wilson, Lesley-Ann
    Limburg, Paul J.
    Helmueller, Leah R.
    Janeiro, Maria Joao
    Hartlaub, Paul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S107 - S107
  • [7] Estimated life-years gained and resultant cost savings from follow-up colonoscopy after a positive multi-target stool DNA (mt-sDNA) test for colorectal cancer screening in commercially insured and Medicare populations.
    Fendrick, A. Mark
    Kisiel, John B.
    Ebner, Derek W.
    Vahdat, Vahab
    Ozbay, A. Burak
    Estes, Chris
    Limburg, Paul J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] COLORECTAL CANCER SCREENING: COMPLIANCE WITH MULTI-TARGET STOOL DNA TESTING AMONG MEDICARE BENEFICIARIES
    Swartz, Rebecca
    Weiser, Emily
    Parks, Philip
    Van Thomme, Jack
    Limburg, Paul
    Berger, Barry M.
    GASTROENTEROLOGY, 2019, 156 (06) : S601 - S601
  • [9] Adherence to mt-sDNA testing for colorectal cancer screening among new users in a US Black population
    Greene, Mallik
    Gohil, Shrey
    Camardo, Mark
    Ozbay, A. Burak
    Limburg, Paul
    Lovelace, Jerry
    CURRENT MEDICAL RESEARCH AND OPINION, 2025,
  • [10] Patient-provider communication factors associated with mt-sDNA screening for colorectal cancer.
    Alam, Shama
    Zhu, Xuan
    Madson, Gabriel
    Squiers, Linda
    Helmueller, Leah
    Southwell, Brian
    Gates, Carlye
    Kneedler, Bonny
    Limburg, Paul J.
    Rutten, Lila J. Finney
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)